NICE recommends Sogroya for growth hormone deficiency in children
Pharma Times
JUNE 4, 2025
Treatment provides option for children with growth failure
Pharma Times
JUNE 4, 2025
Treatment provides option for children with growth failure
Viseven
JUNE 4, 2025
Have you ever stopped to wonder how your communication methods are shaping patient loyalty? It’s easy to assume patients will stay if the care is good — but is that enough in today’s digital world? A 2024 survey from Bandwidth revealed that nearly half of patients would consider switching healthcare providers if their communication needs weren’t met.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World Pharma News
JUNE 4, 2025
University of Otago - Ōtākou Whakaihu Waka researchers have been part of two groundbreaking studies in the battle against drug resistant strains of Mycobacterium tuberculosis, the cause of tuberculosis. Co-author on both studies, Dr Matthew McNeil, of the Department of Microbiology and Immunology, describes tuberculosis as a "massive public health problem" that is challenging to solve.
BioPharma Dive
JUNE 4, 2025
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene therapy applications it later brings to the regulator.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmaceutical Technology
JUNE 4, 2025
Redwire Corporation has secured a contract from Aspera Biomedicines to carry out space-based research on a cancer treatment.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaTech
JUNE 4, 2025
The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.
BioPharma Dive
JUNE 4, 2025
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best to use new bispecific antibodies, and expressed concern about looming cuts to science funding.
pharmaphorum
JUNE 4, 2025
AMPLITUDE study of J&J's Akeega could extend the use of PARP inhibitors to hormone-responsive prostate cancer
European Pharmaceutical Review
JUNE 4, 2025
The European Council is set to begin negotiations with the European Parliament about the pharma package, having agreed its position on the new rules. The proposals comprise of a regulation and directive. Once in place, the package will represent the biggest pharmaceutical reform in over twenty years. Two of its main aims is improving competitiveness of the EU pharmaceutical industry and reducing administrative burden.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JUNE 4, 2025
US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe
Pharma Marketing Network
JUNE 4, 2025
Artificial intelligence is no longer a futuristic conceptit’s here and evolving fast. From automating clinical trials to generating marketing insights, AI in pharma jobs is transforming the healthcare industry. But with automation accelerating, a pressing question emerges: will AI replace pharma jobs or enhance them? Table of Contents The Rise of AI in Pharma Roles Most at Risk (and Why) Emerging Opportunities Through AI Strategic Adaptation for the Pharma Workforce Conclusion FAQs The Ris
pharmaphorum
JUNE 4, 2025
Can a new on-body injector version of Sanofi's Sarclisa help it claim market share from J&J's rival top-selling Darzalex in multiple myeloma
Pharmaceutical Technology
JUNE 4, 2025
The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to potential rivals.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
JUNE 4, 2025
Faced with the looming loss of patent protection for Keytruda, MSD is reported to be interested in buying Swiss immunology player MoonLake
Pharmaceutical Technology
JUNE 4, 2025
Already offering the only non-invasive treatment for SMA in liquid form, Roches Evrysdi now comes as a tablet.
pharmaphorum
JUNE 4, 2025
Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US
Pharmaceutical Technology
JUNE 4, 2025
In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh in the US, ATS 2025 commentary, and more
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Commerce
JUNE 4, 2025
Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one.
Pharmacy Times
JUNE 4, 2025
New findings show LYR-210's potential to significantly alleviate chronic rhinosinusitis symptoms, offering hope for patients with nasal inflammation and polyps.
Pharmaceutical Commerce
JUNE 4, 2025
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Pharmaceutical Technology
JUNE 4, 2025
Agenus has signed $141m partnership agreements with Zydus Lifesciences, expanding patient access to BOT/BAL.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
JUNE 4, 2025
In the final part of his Pharma Commerce video interview, Scott Tillman, Logilitys senior vice president of innovation, discusses how uncertainty can help reshape the way organizations prioritize supply chain investments.
Pharmaceutical Technology
JUNE 4, 2025
The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).
Pharmacy Times
JUNE 4, 2025
Saad Usmani, MD, MBA, FACP, FASCO, explores treatment duration, patient characteristics, and toxicity profiles in transplant-ineligible patients with newly diagnosed multiple myeloma.
FDA Law Blog: Biosimilars
JUNE 4, 2025
By Mark A. Tobolowsky & Ricardo Carvajal Among other things, EO 14212 established the Make America Healthy Again (MAHA) Commission (with HHS Secretary Kennedy as its Chair) and tasked it with a tall order: submission to the President of an Assessment that tackled 10(!) complex public health issues within 100(!) days. Perhaps it was inevitable that the Commission would turn to AI for help, as seems to have been the case in light of media reports that the Assessment as originally published in
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 4, 2025
Results from the NeoADAURA trial demonstrate the sustained efficacy of osimertinib in patients with epidermal growth factor receptor-mutated (EGFRm) non-small-cell lung cancer (NSCLC).
STAT
JUNE 4, 2025
Chronic disease isn’t going away, but a national center devoted to its prevention may be, a prospect that is alarming agency insiders and public health officials across the country. The Department of Health and Human Services’ budget for 2026 , released Friday, proposed $14 billion in discretionary funding for programs that aim to reverse the chronic disease epidemic , but it would also abolish the CDC’s National Center for Chronic Disease Prevention and Health Promotion.
Pharmacy Times
JUNE 4, 2025
Ibrutinib plus venetoclax shows promising long-term survival rates, including those who are considered high risk.
Let's personalize your content